FDA Inspection
ImprimisRx CA, Inc., dba ImprimisRxImprimisRx CA, Inc., dba ImprimisRx – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns ImprimisRx CA, Inc., dba ImprimisRx, with an inspection on March 31, 2017, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 0348a645-ed8b-41d9-8562-d9264b8c7e7d
Inspection Facts
- Inspection number
- 1010017
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.42(c)(10)(iii)Air Supply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ImprimisRx CA, Inc., dba ImprimisRx
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ImprimisRx CA, Inc., dba ImprimisRx
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.